Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Costs of subcutaneous and intravenous administration of trastuzumab for patients with HER2-positive breast cancer

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Localization, distribution, and connectivity of neuropeptide Y in the human and porcine retinas - a comparative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Melanopsin expressing human retinal ganglion cells: Subtypes, distribution and intraretinal connectivity

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sex differences in the photoperiodic regulation of RF-Amide related peptide (RFRP) and its receptor GPR147 in the syrian hamster

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Molecular subtyping of breast cancer improves identification of both high and low risk patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mortality and recurrence rates among systemically untreated high risk breast cancer patients included in the DBCG 77 trials

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Jens Olsen
  • Kenneth Forsstrøm Jensen
  • Daniel Sloth Olesen
  • Ann Knoop
View graph of relations

AIM: Trastuzumab is available in an intravenous (iv.) and a subcutaneous (sc.) formulation. The objective of this study was to estimate the costs of administration of iv. and sc. trastuzumab treatment.

MATERIALS & METHODS: Via interviews, we identified all the activities associated with iv. and sc. administration. The outcome was time estimates. To estimate the administration costs, the time estimates were valued by average gross wages.

RESULTS: The iv. administration takes longer time as infusion time is longer (25 or 85 min). The iv. administration is associated with higher cost for 17 cycles; €971 (€1858 vs €887).

CONCLUSION: sc. administration is associated with lower administration costs. Switching patients from iv. to sc. would make it possible to treat more patients without increasing the personnel resources.

Original languageEnglish
JournalJournal of Comparative Neurology
Volume7
Issue number5
Pages (from-to)411-419
ISSN0021-9967
DOIs
Publication statusPublished - 2018

    Research areas

  • Journal Article

ID: 52174644